Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Baxter
Federal Trade Commission
Fuji
Deloitte
Chinese Patent Office
Boehringer Ingelheim
McKinsey
Express Scripts
Cantor Fitzgerald
Farmers Insurance

Generated: October 22, 2017

DrugPatentWatch Database Preview

Insulin recombinant purified human - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for insulin recombinant purified human and what is the scope of insulin recombinant purified human freedom to operate?

Insulin recombinant purified human
is the generic ingredient in four branded drugs marketed by Novo Nordisk Inc and Bayer Pharms, and is included in four NDAs. Additional information is available in the individual branded drug profile pages.

There are thirty-eight drug master file entries for insulin recombinant purified human.

Summary for Generic Name: insulin recombinant purified human

US Patents:0
Tradenames:4
Applicants:2
NDAs:4
Drug Master File Entries: see list38
Clinical Trials: see list11,903
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:insulin recombinant purified human at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Novo Nordisk Inc
NOVOLIN R
insulin recombinant purified human
INJECTABLE;INJECTION018778-001Aug 30, 1983DISCNNoNo► Subscribe► Subscribe► Subscribe
Novo Nordisk Inc
NOVOLIN 70/30
insulin recombinant purified human; insulin susp isophane semisynthetic purified human
INJECTABLE;INJECTION019441-001Jul 11, 1986DISCNNoNo► Subscribe► Subscribe► Subscribe
Novo Nordisk Inc
VELOSULIN BR HUMAN
insulin recombinant purified human
INJECTABLE;INJECTION019450-001May 30, 1986DISCNNoNo► Subscribe► Subscribe► Subscribe
Bayer Pharms
MIXTARD HUMAN 70/30
insulin recombinant purified human; insulin susp isophane semisynthetic purified human
INJECTABLE;INJECTION019585-001Mar 11, 1988DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Baxter
UBS
Cipla
Fish and Richardson
Express Scripts
Boehringer Ingelheim
Harvard Business School
US Army
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot